Fortress Biotech, Inc. ("Fortress”) is an innovative biopharmaceutical company focused on acquiring and advancing assets to ...

XOMA Royalty Corporation (NASDAQ: XOMA), the biotech royalty aggregator, announced today its Chief Executive Officer, Owen ...

With long development timelines and high burn rates, biotech companies must navigate capital markets with precision.

Vinay Prasad, an academic and fierce critic of the medical mainstream, has been chosen to be the next director of the FDA ...

The Inflation Reduction Act did nothing for me to reduce costs and I’m sure many others.

Officials in sixteen states and the District of Columbia sued in response, leading to Tuesday’s order from U.S. District ...

Zealand Pharma Announces Financial Results for the First Three Months of 2025 Significant progress in the clinical pipeline, ...

The meeting was with a startup created by Flatiron Health veterans Josh Haimson and Ben Birnbaum. The duo had built the first ...

The antitoxin antibodies found in the blood of a Wisconsin man—who voluntarily let snakes bite him for alm0st 20 years—is ...

CRISPR Therapeutics has reported reductions in triglycerides and LDL cholesterol of more than 80% after a single dose of its ...

Neurocrine Biosciences has handed back two discovery-stage gene therapy programs to Voyager Therapeutics, although the ...

Already facing headwinds caused by a patient’s death and treatment delays, the biotech now may have to contend with a less friendly FDA.